Science & Technology
Science and Technology
Science and Technology
Tue, December 30, 2008
Mon, December 29, 2008 iCAD announces availability of its SecondLook Digital with Agfa HealthCares CR Digitizers in Europe
NASHUA, N.H.--([ BUSINESS WIRE ])--iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of advanced image analysis and workflow solutions for the early identification of cancer, today announced that its SecondLook® Digital CAD technology customized for use with Agfa HealthCare's Computed Radiography Systemsis now available throughout Europe.
"iCAD for CR Mammography has simplified life and makes us more efficient", said Dr. Fenzl, M.D., Head of Radiology for Diagnostic and Interventional Radiology and Nuclear Medicine at Bundes-Knappschaftkrankenhaus Püttlingen, Saarland in Germany. He continued, "In fact iCAD is a great aid where it comes to challenging mammography cases as it helps detecting difficult to spot cancers. At the beginning I was rather skeptical and kept a certain distance. However, after having used the iCAD system for a couple of weeks it has really added value. It increases confidence and it would be hard to go back to the days where iCAD was not used. Our radiologists are using it on a daily basis and it smoothly integrates in our digital workflow. "
iCAD has received CE mark approval to market and sell its customized solution with Agfa HealthCare's Computed Radiography Systemsand units have been placed at Bundes-Knappschaftkrankenhaus Püttlingen in Germany.
"The availability of our CAD technology with Agfa Healthcare's solutions in Europe marks another milestone in our business strategy to increase the use of iCAD systems outside of the U.S.," said Ken Ferry, President and CEO of iCAD. "Our new partnership underscores Agfa's leadership in diagnostic image management solutions and our shared commitment to improving early detection of breast cancer in Europe."
About Agfa HealthCare
Agfa HealthCare, a member of the Agfa-Gevaert Group, is a leading provider of IT-enabled clinical workflow and diagnostic image management solutions, and state-of-the-art systems for capturing and processing images in hospitals and healthcare facilities. Agfa HealthCare has over a century of healthcare experience related to diagnostic imaging and has been a pioneer on the healthcare IT market since the early 1990's. The HealthCare division has sales offices and agents in over 100 markets worldwide. Sales for Agfa HealthCare in 2007 were 1,392 million Euro, accounting for 43% of total group sales.
About iCAD, Inc.
iCAD, Inc. is an industry-leading provider of advanced image analysis and workflow solutions that enable healthcare professionals to better serve patients by identifying pathologies and pinpointing cancer earlier. iCAD offers a comprehensive range of high-performance, upgradeable Computer-Aided Detection (CAD) systems and workflow solutions for mammography (film-based, digital radiography (DR) and computed radiography (CR), Magnetic Resonance Imaging (MRI), and Computed Tomography (CT). Currently available in more than 2,200 healthcare centers worldwide, iCAD's solutions aid in the early detection of the most prevalent cancers including breast, colon, prostate and in the future, lung cancer. For more information, call (877) iCADnow or visit [ www.icadmed.com ].
"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995:
Certain statements contained in this News Release constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve a number of known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors include, but are not limited to, the risks of uncertainty of patent protection, the impact of supply and manufacturing constraints or difficulties, product market acceptance, possible technological obsolescence, increased competition, customer concentration and other risks detailed in the Company's filings with the Securities and Exchange Commission. The words "believe", "demonstrate", "intend", "expect", "estimate", "anticipate", "likely", and similar expressions identify forward-looking statements. Readers are cautioned not to place undue reliance on those forward-looking statements, which speak only as of the date the statement was made. The Company is under no obligation to provide any updates to any information contained in this release.
